Tumor-like Lesions of the Musculoskeletal System

2022 ◽  
pp. 157-166
Author(s):  
Leonardo Leonardi
Keyword(s):  
Musculoskeletal System ◽  
Tumor Like Lesions

scholarly journals THE EVALUATION OF MUSCULOSKELETAL SYSTEM TUMORS AND TUMOR-LIKE LESIONS IN THRACE REGION

2018 ◽  
pp. 50-53
Author(s):  
Ece Şenyiğit ◽  
Begüm Söyleyici ◽  
Nur Gülce İşkan ◽  
Hilal Sena Çifcibaşı ◽  
Aslı Göztepe ◽  
...  
Keyword(s):  
Musculoskeletal System ◽  
Tumor Like Lesions ◽  
Thrace Region

Fifth Edition: the New Standard

2000 ◽  
Vol 5 (6) ◽  
pp. 1-7
Author(s):  
Christopher R. Brigham ◽  
James B. Talmage ◽  
Leon H. Ensalada
Keyword(s):  
Musculoskeletal System ◽  
Medical Information ◽  
Objective Assessment ◽  
Scientific Data ◽  
Practical Application ◽  
Fourth Edition ◽  
Appropriate Use ◽  
Medical Evaluation ◽  
Single Set

Abstract The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Fifth Edition, is available and includes numerous changes that will affect both evaluators who and systems that use the AMA Guides. The Fifth Edition is nearly twice the size of its predecessor (613 pages vs 339 pages) and contains three additional chapters (the musculoskeletal system now is split into three chapters and the cardiovascular system into two). Table 1 shows how chapters in the Fifth Edition were reorganized from the Fourth Edition. In addition, each of the chapters is presented in a consistent format, as shown in Table 2. This article and subsequent issues of The Guides Newsletter will examine these changes, and the present discussion focuses on major revisions, particularly those in the first two chapters. (See Table 3 for a summary of the revisions to the musculoskeletal and pain chapters.) Chapter 1, Philosophy, Purpose, and Appropriate Use of the AMA Guides, emphasizes objective assessment necessitating a medical evaluation. Most impairment percentages in the Fifth Edition are unchanged from the Fourth because the majority of ratings currently are accepted, there is limited scientific data to support changes, and ratings should not be changed arbitrarily. Chapter 2, Practical Application of the AMA Guides, describes how to use the AMA Guides for consistent and reliable acquisition, analysis, communication, and utilization of medical information through a single set of standards.

Quick Reference: Chapter 3: The Musculoskeletal System and Chapter 4: The Nervous System

2000 ◽  
Vol 5 (3) ◽  
pp. 4-4
Keyword(s):  
Nervous System ◽  
Lower Extremity ◽  
Musculoskeletal System ◽  
Multistep Method ◽  
Manual Muscle Testing ◽  
Motor Deficits ◽  
Lower Extremity Weakness ◽  
Residual Symptoms ◽  
Muscle Testing ◽  
Almost All

Abstract Lesions of the peripheral nervous system (PNS), whether due to injury or illness, commonly result in residual symptoms and signs and, hence, permanent impairment. The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides), Fourth Edition, divides PNS deficits into sensory and motor and includes pain in the former. This article, which regards rating sensory and motor deficits of the lower extremities, is continued from the March/April 2000 issue of The Guides Newsletter. Procedures for rating extremity neural deficits are described in Chapter 3, The Musculoskeletal System, section 3.1k for the upper extremity and sections 3.2k and 3.2l for the lower limb. Sensory deficits and dysesthesia are both disorders of sensation, but the former can be interpreted to mean diminished or absent sensation (hypesthesia or anesthesia) Dysesthesia implies abnormal sensation in the absence of a stimulus or unpleasant sensation elicited by normal touch. Sections 3.2k and 3.2d indicate that almost all partial motor loss in the lower extremity can be rated using Table 39. In addition, Section 4.4b and Table 21 indicate the multistep method used for spinal and some additional nerves and be used alternatively to rate lower extremity weakness in general. Partial motor loss in the lower extremity is rated by manual muscle testing, which is described in the AMA Guides in Section 3.2d.

Common Benign Cutaneous Tumors And Tumor-Like Lesions Of The Head And Neck

1993 ◽  
Vol 26 (2) ◽  
pp. 145-165
Author(s):  
Alberto A. Diaz-Arias ◽  
Timothy S. Loy ◽  
John D. DeSpain
Keyword(s):  
Head And Neck ◽  
Tumor Like Lesions

Avipoxvirus detected in tumor-like lesions in a white-faced whistling duck (Dendrocygna viduata)

2020 ◽  
Vol 40 (10) ◽  
pp. 818-823
Author(s):  
Juliana F.V. Braga ◽  
Rodrigo M. Couto ◽  
Marcelo C. Rodrigues ◽  
Roselene Ecco
Keyword(s):  
Squamous Cell Carcinoma ◽  
Phylogenetic Analysis ◽  
Protein Gene ◽  
Core Protein ◽  
Avian Species ◽  
Tissue Samples ◽  
Histopathological Evaluation ◽  
In Captivity ◽  
Avian Pox ◽  
Tumor Like Lesions

ABSTRACT: Avipoxvirus is the etiological agent of the avian pox, a well-known disease of captive and wild birds, and it has been associated with tumor-like lesions in some avian species. A white-faced whistling duck (Dendrocygna viduata) raised in captivity was referred to a Veterinary Teaching Hospital in Northeast due to cutaneous nodules present in both wings. A few days after the clinical examination, the animal died naturally. Once submitted to necropsy, histopathological evaluation of the lesions revealed clusters of proliferating epithelial cells expanding toward the dermis. Some of these cells had round, well-defined, intracytoplasmic eosinophilic material suggestive of poxvirus inclusion (Bollinger bodies). PCR performed on the DNA extracted from tissue samples amplified a fragment of the 4b core protein gene (fpv167), which was purified and sequenced. This fragment of Avipoxvirus DNA present in these tumor-like lesions showed high genetic homology (100.0%) with other poxviruses detected in different avian species in several countries, but none of them were related to tumor-like lesions or squamous cell carcinoma. This is the first report of Avipoxvirus detected in tumor-like lesions of a white-faced whistling duck with phylogenetic analysis of the virus.

Pathological Hip Fractures in Children and Adolescents Due to Benign Tumor or Tumor-Like Lesions

2019 ◽  
Vol 29 (2) ◽  
pp. 91-99
Author(s):  
Georgios Vynichakis ◽  
Stavros Angelis ◽  
Michail Chandrinos ◽  
Alexandros P. Apostolopoulos ◽  
Elefterios Bogris ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Hip Fractures ◽  
Benign Tumor ◽  
Fractures In Children ◽  
Tumor Like Lesions

Specialized Food Product with Directed Systemic Action: Innovative Technological Solutions, Performance Evaluation

Food Industry ◽  
2020 ◽  
Vol 5 (1) ◽  
pp. 58-64
Author(s):  
Andrey Vekovtsev ◽  
Tokhiriyon Boisjoni ◽  
Badarch Bayambaa ◽  
Victor Shelepov
Keyword(s):  
Musculoskeletal System ◽  
Food Product ◽  
Biologically Active ◽  
Innovative Technology ◽  
Manganese Sulfate ◽  
Mineral Complex ◽  
Technological Production ◽  
Clinical Investigations ◽  
Active Additive ◽  
Macro Nutrients

The authors developed composition and innovative technology of a new specialized product in the form of a biologically active additive to normalize metabolic processes in the case of the musculoskeletal system damage. They obtained specialized product through innovative tableting technology providing high consumer properties, components preservation and its active principles. The technological solutions innovativeness enables to separate composition ingredients considering its chemical and pharmacological incompatibility, and to deliver it sequentially to various sections of the gastrointestinal tract at a given speed. Glucosamine sulfate as a part of the vitamin and mineral complex combining with minerals (micro- and macro-nutrients) – manganese sulfate, calcium hydroxyapatate, cholecoleceferol, zinc and magnesium oxides – have unidirectional functional properties related to the metabolism correction in case of the musculoskeletal system damage. Clinical investigations confirmed the vitamin and mineral complex effectiveness. The diet for children 8- 14 years old has included one capsule of the specialized product additionally three times a day. Children (3-7 years old) with the long tubular bones fracture have received one capsule twice a day. Authors tested the recipe and technological production parameters at the enterprises of the company “Artlife” under the conditions of international and domestic standards including GMP and guaranteeing the quality indicators and competitiveness stability.

Sign in / Sign up

Export Citation Format

Share Document